Annunziata Lapolla

Pentosidine Formation in Skin Correlates With Severity of Complications in Individuals With Long-Standing IDDM

David R. Sell, Annunziata Lapolla, Patrizio Odetti et al. · Diabetes · 1992 · 301 citations

Medicine, Biochemistry, Endocrinology +14

Efficacy and safety of dapagliflozin in patients with inadequately controlled type 1 diabetes (DEPICT-1): 24 week results from a multicentre, double-blind, phase 3, randomised controlled trial

Paresh Dandona, Chantal Mathieu, Moshe Phillip et al. · The Lancet Diabetes & Endocrinology · 2017 · 292 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +10

Effects on the incidence of cardiovascular events of the addition of pioglitazone versus sulfonylureas in patients with type 2 diabetes inadequately controlled with metformin (TOSCA.IT): a randomised, multicentre trial

Olga Vaccaro, Maria Masulli, Antonio Nicolucci et al. · The Lancet Diabetes & Endocrinology · 2017 · 290 citations

Medicine, Endocrinology, Pharmacology +11

Glyoxal and Methylglyoxal Levels in Diabetic Patients: Quantitative Determination by a New GC/MS Method

Annunziata Lapolla, Riccardo Flamini, Antonio Dalla Vedova et al. · Clinical Chemistry and Laboratory Medicine (CCLM) · 2003 · 284 citations

Life Sciences, Biochemistry, Diabetology +16

Efficacy and Safety of Dapagliflozin in Patients With Inadequately Controlled Type 1 Diabetes: The DEPICT-1 52-Week Study

Paresh Dandona, Chantal Mathieu, Moshe Phillip et al. · Diabetes Care · 2018 · 238 citations

Medicine, Pharmacology, Pharmacotherapy +17